Blog
3 Safe Stocks for a Coming Market Crash
Last month's slump was a reminder of how quickly the market can go from a rally to a pullback. In this case, the situation is looking bright. The S&P 500 has rebounded more than 7% since its
Regions Financial Should Beat Earnings Consensus
Regions Financial (NYSE: RF), an Alabama-based bank with $144 billion in assets, is expected to have a much better third quarter than it did last quarter when the bank reported a $237 million loss
Up 147% Since March, Is Stanley Black & Decker Stock Still a Good Value?
Having doubled in price since the trough in early March Stanley Black & Decker (NYSE: SWK) stock has had a great run in the last several months. Moreover, it now trades on at more than 32 times
Is Netflix a No-Brainer Buy?
It's no secret that I like Netflix (NASDAQ: NFLX), both the company and the stock. The streaming video veteran is the largest component of my real-money holdings and accounts for 30% of my Motley
What's Going On at Alteryx?
For a long while, shareholders of Alteryx (NYSE: AYX) probably thought the company could do no wrong. The ride wasn't always smooth, but in the three years leading up to mid-August, its shares had
3 Top Breakout Stocks to Buy Right Now
If you're a fan of growth investing, you know it makes sense to look for companies you can buy as they're just starting to break away from the pack, then sell when they can no longer deliver good
JetBlue Upgraded and Downgraded: What's Next?
JetBlue Airways (NASDAQ: JBLU) stock got a big upgrade from J.P. Morgan analysts last Wednesday. Less than 24 hours later, however, Fitch -- one of the three major credit rating agencies -- cut the
4 Marijuana Stocks to Buy for Q4 and Beyond
Throughout 2020, tech stocks have dominated discussion within the investment community. But when it comes to high-growth potential, don't discount cannabis.
There's no question that expectations got
The Top 2 Contrarian Stocks to Buy Right Now
Back in 1993, when drugmaker Amarin's (NASDAQ: AMRN) shares first hit the market, it might have cost you $1,425 to buy one share (adjusted for splits). Go forward a few decades, and that one share
SpaceX and L3Harris Team Up to Build Satellites for the Space Force
Five years ago, Elon Musk had a dream.
Rather than just build space rockets to carry other companies' satellites into orbit -- leaving SpaceX's business dependent upon the demand of third parties --
Forget Tesla! Intuitive Surgical Is a Better Growth Stock
Electric vehicle pioneer Tesla (NASDAQ: TSLA) is attempting to revolutionize the automobile industry, and with visionary CEO Elon Musk at the helm, it looks to have a bright future in a fast-growing
Is the Coronavirus Vaccine Market Oversaturated?
Stocks of coronavirus vaccine candidate developers have been on fire this year. If you invested in a balanced portfolio consisting of the five most prominent COVID-19 vaccine developers in the
2 Top Pharma Stocks to Buy in October
Over the past 10 years, pharmaceutical stocks have consistently outperformed major indices, with the Dow Jones US Pharmaceutical & Biotechnology Index up nearly 202% over that time period compared
4 Reasons Warren Buffett Can't Stomach Bitcoin
If there's one thing Warren Buffett will never ever invest in, it's bitcoin -- or any other cryptocurrency. He's called it "rat poison squared," a "mirage," and a "gambling device."
But if there's
3 Things You Need to Know Before Retiring
If you've worked for many years and are reaching the age when many of your peers are gearing up to retire, then you may be thinking about that milestone as well. But retiring requires careful
Forget FAANG, Buy These 4 Top-Notch Stocks Instead
Over the course of the past decade, investors who put their money to work in the vaunted FAANG stocks -- Facebook, Amazon (NASDAQ: AMZN), Apple, Netflix, and Alphabet -- have beaten the broader
Coronavirus Vaccine Side Effects: 3 Key Things You Need to Know
Four coronavirus vaccine candidates have advanced to late-stage clinical trials in the U.S., and another should begin late-stage testing soon. One main purpose of these clinical studies is to
Only Have $500 to Invest? Buy These 3 Great Stocks
Sure, it takes money to make money. However, that adage scares away some people who don't think they have enough money to even begin investing in stocks.
The reality is that you can get started
These 15 Stocks Have Paid a Dividend for 125 (or More) Consecutive Years
There's no question that growth stocks are getting all the attention on Wall Street right now. But when push comes to shove, growth stocks have historically taken a back seat to dividend stocks over
Can Little Novavax Beat Its Big Coronavirus Vaccine Rivals?
It's not surprising that several of the biggest drugmakers in the world have emerged as leaders in the race to develop a coronavirus vaccine. After all, they have vast resources. Some developed
Biden or Trump? Survey Reveals Americans' Views on Future of Social Security
Just in case it may have somehow slipped your mind amid the barrage of news coverage, ads, and tweets, there's a political election coming up this November. The differences between the candidates
3 Rookie Mistakes Robinhood Investors Can't Afford to Make
Robinhood has become an incredibly popular brokerage choice for investors,in large part due to its ease of use and the fact it works hard to make investing more accessible and more fun. Not
4 Things the Eaton Vance Acquisition Taught Us About Morgan Stanley
Morgan Stanley's (NYSE: MS) acquisition of Eaton Vance (NYSE: EV) is the bank's second big move of 2020, after it acquired E*Trade earlier in the year. Morgan Stanley has spent $20 billion combined
3 Must-Own Growth Stocks for Robinhood Investors
Investing in 2020 has been quite the adventure -- and there's still 2-1/2 months to go before we close out the year. Thus far, we've witnessed a record-breaking tumble of 34% in the S&P 500 that
3 Reasons To Buy Curaleaf Stock Now
Curaleaf Holdings (OTC: CURLF) has had a good year, and it's likely to get better once November rolls around. Shares of the Massachusetts cannabis company are up more than 41% year to date, and


